Market Monitor chemicals Germany 2019

Market Monitor

  • Germany
  • Chemicals/Pharma

16th July 2019

Due to the more difficult market environment and decreasing sales, we have recently downgraded the sector performance outlook from “Excellent” to “Good”.

 

2019 ger chem 1

The German chemicals industry (including pharmaceuticals) is the largest chemicals industry in Europe and the fourth largest in the world. Of the about 2,000 companies that produce chemical products, more than 90% are small and medium-sized enterprises (SMEs) with less than 500 staff members. SMEs employ one third of the workforce and account for almost one third of total chemicals industry sales. Unlike in other industries, chemicals SMEs are often customers, not suppliers of large chemicals companies.

According to the German chemicals association VCI, production excluding pharmaceuticals decreased 2.2% in 2018 (including pharmaceuticals: up 3.6%), while turnover decreased 3.8%, to EUR 203 billion. VCI expects both production and turnover to deteriorate again in 2019, by 4.0% and 3.0% respectively.|

This forecast decline is mainly due to lower economic growth in Europe, coupled with  less demand from key buyer industries (such as automotive). Additionally the sector is affected by higher insecurity in the global economy over the repercussions of protectionism (e.g. the Sino-US trade dispute and the threat of potential US tariffs on car imports from the EU). At the same time, international competition is increasing for German chemical businesses, mainly from Asian producers constantly climbing up the value chain (e.g. higher knowledge in the special chemicals segment).

Generally, German chemicals and pharmaceuticals businesses have robust equity, solvency and liquidity. However, pressure on profit margins of German chemical businesses is expected to increase, due to a more volatile economic cycle and increasing international competition. In global comparison labour, energy, commodity costs and regulatory standards are high.

The German chemicals sector’s payment behaviour has always been better than average with no notable payment delays. Payments take 45 days on average, even fewer for domestic payments, as most chemical products are exported to destinations with longer payment terms than the domestic market. We have seen no major change in payment behaviour or increase in notifications of non-payment in the last six months, and this trend is expected to continue in the coming months. The insolvency environment is stable, with insolvencies expected to remain at a low level.

Due to the still benign credit risk situation our underwriting stance for this sector remains generally relaxed, with normal external monitoring and buyer reviews. However, due to the more difficult market environment we have recently downgraded the sector performance outlook from “Excellent” to “Good”. 

Related Documents

Disclaimer

Each publication available on or from our websites, such as, but not limited to webpages, reports, articles, publications, tips and helpful content, trading briefs, infographics, videos (each a “Publication”) is provided for information purposes only and is not intended as a recommendation or advice as to particular transactions, investments or strategies in any way to any reader. Readers must make their own independent decisions, commercial or otherwise, regarding the information provided. While we have made every attempt to ensure that the information contained in any Publication has been obtained from reliable sources, Atradius is not responsible for any errors or omissions, or for the results obtained from the use of this information. All information in any Publication is provided ’as is’, with no guarantee of completeness, accuracy, timeliness or of the results obtained from its use, and without warranty of any kind, express or implied. In no event will Atradius, its related partnerships or corporations, or the partners, agents or employees thereof, be liable to you or anyone else for any decision made or action taken in reliance on the information in any Publication, or for any loss of opportunity, loss of profit, loss of production, loss of business or indirect losses, special or similar damages of any kind, even if advised of the possibility of such losses or damages.